President and CEO Dr. Frank Bedu-Addo Provides an Update on the State of PDS Biotech

Creating a circular economy for anaesthetic gases

Lord Callahan, Energy Efficiency Minister, opens Q-Bot’s new head office in London

Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

Telecoms Trailblazers: A Day in the Life of David Wither

Costs and Consequences of a Novel Emergency Department Sepsis Diagnostic Test: The IntelliSep Index

PDS Biotech to Present Immune Response Data from Combination of PDS0101 and KEYTRUDA® (pembrolizumab) in Head and Neck Cancer Patients at ESMO Congress 2023

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab

PDS Biotech Announces Acceptance of Abstract on Combination of PDS0301 with Docetaxel in Metastatic Prostate Cancer for Oral Presentation by the National Cancer Institute at Cytokines 2023

PDS Biotech Strengthens Intellectual Property Portfolio Governing A Combination of Versamune® and PDS0301